California Nanotechnologies (FRA:R14) ROE %: -195.01% (As of Nov. 2025)


FRA:R14 California Nanotechnologies Corp FRA:R14
40 GF Score
Price €0.14
GF Value €0.18
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is California Nanotechnologies ROE %?

California Nanotechnologies FRA:R14 -11.39% 40 ROE % is -195.01% as of Nov. 2025. GuruFocus rates FRA:R14 with a GF Score™ of 40/100 and a GF Value™ of €0.18 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,586 Chemicals companies, California Nanotechnologies ranks worse than 97.41% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. California Nanotechnologies's annualized net income for the quarter that ended in Nov. 2025 was €-3.79 Mil. California Nanotechnologies's average Total Stockholders Equity over the quarter that ended in Nov. 2025 was €1.94 Mil. Therefore, California Nanotechnologies's annualized ROE % for the quarter that ended in Nov. 2025 was -195.01%.

The historical rank and industry rank for California Nanotechnologies's ROE % or its related term are showing as below:

FRA:R14' s ROE % Range Over the Past 10 Years
Min: -99.91   Med: -12.88   Max: -12.88
Current: -99.91

During the past 13 years, California Nanotechnologies's highest ROE % was -12.88%. The lowest was -99.91%. And the median was -12.88%.

FRA:R14's ROE % is ranked worse than
97.41% of 1586 companies
in the Chemicals industry
Industry Median: 5.185 vs FRA:R14: -99.91

California Nanotechnologies  (FRA:R14) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Nov. 2025 )
=Net Income/Total Stockholders Equity
=-3.788/1.9425
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-3.788 / 1.356)*(1.356 / 3.6585)*(3.6585 / 1.9425)
=Net Margin %*Asset Turnover*Equity Multiplier
=-279.35 %*0.3706*1.8834
=ROA %*Equity Multiplier
=-103.53 %*1.8834
=-195.01 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Nov. 2025 )
=Net Income/Total Stockholders Equity
=-3.788/1.9425
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-3.788 / -3.776) * (-3.776 / -2.856) * (-2.856 / 1.356) * (1.356 / 3.6585) * (3.6585 / 1.9425)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0032 * 1.3221 * -210.62 % * 0.3706 * 1.8834
=-195.01 %

Note: The net income data used here is four times the quarterly (Nov. 2025) net income data. The Revenue data used here is four times the quarterly (Nov. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


California Nanotechnologies ROE % Related Terms


California Nanotechnologies ROE % Historical Data

* Premium members only.

The historical data trend for California Nanotechnologies's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

California Nanotechnologies ROE % Chart

California Nanotechnologies Annual Data
Trend Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 Negative Equity Negative Equity Negative Equity -12.89

California Nanotechnologies Quarterly Data
Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.53 -61.81 -76.55 -50.68 -195.01

FRA:R14 vs LIN, SHW, ECL: ROE % Comparison

For the Specialty Chemicals subindustry, California Nanotechnologies's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


California Nanotechnologies ROE % vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, California Nanotechnologies's ROE % distribution charts can be found below:

* The bar in red indicates where California Nanotechnologies's ROE % falls into.


FRA:R14
40GF Score
California Nanotechnologies Corp FRA:R14
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

California Nanotechnologies ROE % Calculation

California Nanotechnologies's annualized ROE % for the fiscal year that ended in Feb. 2025 is calculated as

ROE %=Net Income (A: Feb. 2025 )/( (Total Stockholders Equity (A: Feb. 2024 )+Total Stockholders Equity (A: Feb. 2025 ))/ count )
=-0.152/( (0.135+2.223)/ 2 )
=-0.152/1.179
=-12.89 %

California Nanotechnologies's annualized ROE % for the quarter that ended in Nov. 2025 is calculated as

ROE %=Net Income (Q: Nov. 2025 )/( (Total Stockholders Equity (Q: Aug. 2025 )+Total Stockholders Equity (Q: Nov. 2025 ))/ count )
=-3.788/( (2.036+1.849)/ 2 )
=-3.788/1.9425
=-195.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Nov. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -195.01% mean?
California Nanotechnologies (FRA:R14) has a ROE % of -195.01% as of Nov. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on California Nanotechnologies and its competitors. According to the industry distribution chart, California Nanotechnologies ranks #1545 out of 1586 companies in the Chemicals industry, placing it in the top 97.4%.
Is California Nanotechnologies' ROE % too high?
California Nanotechnologies' current ROE % is -195.01%. Based on the distribution chart, California Nanotechnologies ranks #1545 out of 1586 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, California Nanotechnologies has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does California Nanotechnologies' ROE % compare to LIN and SHW?
According to the Chemicals industry distribution chart, California Nanotechnologies ranks #1545 out of 1586 companies for ROE %. This places California Nanotechnologies in the lower half of its industry. The industry median ROE % is 5.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Chemicals company?
The median ROE % among Chemicals companies is 5.19, based on 1,586 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on California Nanotechnologies and its competitors. For the Chemicals industry, the median ROE % is 5.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. California Nanotechnologies's current ROE % is -195.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is California Nanotechnologies stock overvalued right now?
Based on GuruFocus' analysis, California Nanotechnologies (FRA:R14) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.18, compared to a current price of €0.14 — trading 22.2% below its estimated fair value. The current ROE % is -195.01%. California Nanotechnologies' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For California Nanotechnologies (FRA:R14), the current ROE % is -195.01% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is California Nanotechnologies (FRA:R14) Overvalued in 2026?

Based on GuruFocus' analysis, California Nanotechnologies stock appears to be undervalued. The current stock price of €0.14 is trading 22.2% below its estimated GF Value™ of €0.18. GuruFocus considers California Nanotechnologies to be Modestly Undervalued.

Key valuation signals for FRA:R14:

  • ROE %: -195.01%
  • GF Value™: €0.18 vs. price of €0.14 (22.2% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the FRA:R14 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


California Nanotechnologies Business Description

Other Exchanges CANOF:USACNO:Canada
Address 110 Yonge Street, Suite 1601, Toronto, ON, CAN, M5C 1T4
California Nanotechnologies Corp engages in the production, and research and development of nanostructured components and materials. Its products include High-Strength Graphite Spark tooling, Plasma Sintering Tooling, Tungsten Carbide Tooling, Carbon Graphite Foil, Carbon Felt and Yarn, and others.
40GF Score

Get the complete analysis for FRA:R14

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.14
Price
€0.18
GF Value